GlassScriptPhysician profile
Kyle G Schuyler
NPI 1871882548
$17,636.62
in general payments reported to CMS, 2019-2025
14 companies · $657 in 2025
The $657 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,822 · 2021: $11K · 2022: $616 · 2023: $1,601 · 2024: $2,072 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,564 · Education: $1,500 · Travel and Lodging: $1,178 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $88.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,564.32 |
| Education | $1,500.00 |
| Travel and Lodging | $1,177.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $88.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $6,960.26 | 2021 | |
| Intuitive Surgical, INC. | $6,103.42 | 2021-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $2,468.47 | 2019-2023 | Lithovue, Lumenis Pulse 120h |
| Procept Biorobotics Corporation | $735.40 | 2024-2025 | Aquabeam System |
| Sumitomo Pharma America, INC. | $348.06 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $284.00 | 2023-2024 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $200.75 | 2024-2025 | Prolaris |
| Myovant Sciences INC. | $147.96 | 2021-2022 | |
| Innovation Technologies INC | $134.06 | 2023 | Irrisept |
| Laborie Medical Technologies Corp. | $96.85 | 2023-2024 | Endosheath Technology |
| Biotissue Holdings INC. | $88.29 | 2021 | |
| Astellas Pharma US INC | $26.11 | 2019-2021 | |
| Ambu INC. | $24.99 | 2024 | |
| Pfizer INC. | $18.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Schuyler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.